South Korea · Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 161.49 billion. The enterprise value is 165.88 billion.
| Market Cap | 161.49B |
| Enterprise Value | 165.88B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 2.82% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +2.82% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 19.64% |
| Owned by Institutions (%) | 6.57% |
| Float | 16.10M |
Valuation Ratios
The trailing PE ratio is 28.10 and the forward PE ratio is 17.63.
| PE Ratio | 28.10 |
| Forward PE | 17.63 |
| PS Ratio | 4.21 |
| PB Ratio | 2.61 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.24, with an EV/FCF ratio of -442.70.
| EV / Earnings | 28.81 |
| EV / Sales | 4.32 |
| EV / EBITDA | 17.24 |
| EV / EBIT | 27.60 |
| EV / FCF | -442.70 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.95 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | -56.85 |
| Interest Coverage | 5.06 |
Financial Efficiency
Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 4.91%.
| Return on Equity (ROE) | 9.96% |
| Return on Assets (ROA) | 4.32% |
| Return on Invested Capital (ROIC) | 4.91% |
| Return on Capital Employed (ROCE) | 7.95% |
| Revenue Per Employee | 210.99M |
| Profits Per Employee | 31.63M |
| Employee Count | 182 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.14 |
Taxes
In the past 12 months, OSTEONIC has paid 1.10 billion in taxes.
| Income Tax | 1.10B |
| Effective Tax Rate | 16.01% |
Stock Price Statistics
The stock price has increased by +50.29% in the last 52 weeks. The beta is 1.15, so OSTEONIC's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +50.29% |
| 50-Day Moving Average | 7,069.00 |
| 200-Day Moving Average | 6,825.03 |
| Relative Strength Index (RSI) | 58.89 |
| Average Volume (20 Days) | 217,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 38.40 billion and earned 5.76 billion in profits. Earnings per share was 286.51.
| Revenue | 38.40B |
| Gross Profit | 18.77B |
| Operating Income | 6.01B |
| Pretax Income | 6.85B |
| Net Income | 5.76B |
| EBITDA | 9.62B |
| EBIT | 6.01B |
| Earnings Per Share (EPS) | 286.51 |
Balance Sheet
The company has 16.91 billion in cash and 21.30 billion in debt, giving a net cash position of -4.39 billion or -218.79 per share.
| Cash & Cash Equivalents | 16.91B |
| Total Debt | 21.30B |
| Net Cash | -4.39B |
| Net Cash Per Share | -218.79 |
| Equity (Book Value) | 61.90B |
| Book Value Per Share | 3,085.62 |
| Working Capital | 35.37B |
Cash Flow
In the last 12 months, operating cash flow was 5.71 billion and capital expenditures -6.09 billion, giving a free cash flow of -374.70 million.
| Operating Cash Flow | 5.71B |
| Capital Expenditures | -6.09B |
| Free Cash Flow | -374.70M |
| FCF Per Share | -18.68 |
Margins
Gross margin is 48.89%, with operating and profit margins of 15.65% and 14.99%.
| Gross Margin | 48.89% |
| Operating Margin | 15.65% |
| Pretax Margin | 17.85% |
| Profit Margin | 14.99% |
| EBITDA Margin | 25.05% |
| EBIT Margin | 15.65% |
| FCF Margin | n/a |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.82% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.56% |
| FCF Yield | -0.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.32 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 5 |